Additionally, DPP-4 inhibitors have been shown to improve abnormal liver transaminases levels such as aspartate aminotransferase and alanine transaminase, in patients with T2DM with liver dysfunction
Download Glowiseyour AI partner for calories, nutrition, GLP-1 support, and real progress
Color of this formula may vary due to color variations of the ingredients
Does NEXAPH sell through third-party marketplaces
In some comparisons, statistical heterogeneity was high
doi: 10.3389/fimmu.2025.1690068 Received 21 August 2025 Accepted 03 October 2025 Published 16 October 2025 Volume 16 - 2025 Edited by Adil Rasheed, Augusta University, United States Reviewed by Zhi-Wei Wang, Wenzhou Medical University, China Yang Xiang, Peking Union Medical College Hospital (CAMS), China Updates Copyright 2025 Yang, Li, Shi, Zhong and Xiong